G220 150 (Lithium 150 mg)

Pill imprint G220 150 has been identified as Lithium carbonate 150 mg.

Lithium is used in the treatment of bipolar disorder; borderline personality disorder; schizoaffective disorder; depression; mania (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for G220 150

Lithium carbonate 150 mg G220 150
Lithium carbonate
Imprint:
G220
150
Strength:
150 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Glenmark Generics Inc.
National Drug Code (NDC):
68462-0220
Inactive Ingredients:
FD&C Blue No. 1
FD&C Red No. 40
D&C Yellow No. 10
silicon dioxide
gelatin
sodium lauryl sulfate
magnesium silicate
titanium dioxide
shellac
propylene glycol
potassium hydroxide
ferrosoferric oxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)